Transcription profiling by array of ER-positive breast cancer biopsies taken before and after 4 weeks of fulvestrant treatment
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
Analysis of breast cancer tumors following fulvestrant treatment for 4 weeks. Fulvestrant is a highly specific ER antagonist used to treat postmenopausal women with breast cancer. Data provide insight into the molecular mechanism of action of fulvestrant on whole genome expression.
创建时间：
2016-04-14
